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Background The greatest potential to reduce the burden of
stroke is by primary prevention of first-ever stroke, which
constitutes three quarters of all stroke. In addition to
population-wide prevention strategies (the ‘mass’ approach),
the ‘high risk’ approach aims to identify individuals at risk of
stroke and to modify their risk factors, and risk, accordingly.
Current methods of assessing and modifying stroke risk are
difficult to access and implement by the general population,
amongst whom most future strokes will arise. To help reduce
the burden of stroke on individuals and the population a new
app, the Stroke RiskometerTM, has been developed. We aim to
explore the validity of the app for predicting the risk of stroke
compared with current best methods.
Methods 752 stroke outcomes from a sample of 9501 individu-
als across three countries (New Zealand, Russia and the Neth-
erlands) were utilized to investigate the performance of a
novel stroke risk prediction tool algorithm (Stroke Riskome-
terTM) compared with two established stroke risk score predic-
tion algorithms (Framingham Stroke Risk Score [FSRS] and
QStroke). We calculated the receiver operating characteristics
(ROC) curves and area under the ROC curve (AUROC) with 95%
confidence intervals, Harrels C-statistic and D-statistics for
measure of discrimination, R2 statistics to indicate level of
variability accounted for by each prediction algorithm, the
Hosmer-Lemeshow statistic for calibration, and the sensitivity
and specificity of each algorithm.
Results The Stroke RiskometerTM performed well against the
FSRS five-year AUROC for both males (FSRS = 75·0% (95% CI
72·3%–77·6%), Stroke RiskometerTM = 74·0(95% CI 71·3%–
76·7%) and females [FSRS = 70·3% (95% CI 67·9%–72·8%,
Stroke RiskometerTM = 71·5% (95% CI 69·0%–73·9%)], and
better than QStroke [males – 59·7% (95% CI 57·3%–62·0%) and
comparable to females = 71·1% (95% CI 69·0%–73·1%)]. Dis-
criminative ability of all algorithms was low (C-statistic
ranging from 0·51–0·56, D-statistic ranging from 0·01–0·12).
Hosmer-Lemeshow illustrated that all of the predicted risk
scores were not well calibrated with the observed event data
(P < 0·006).
Conclusions The Stroke RiskometerTM is comparable in perfor-
mance for stroke prediction with FSRS and QStroke. All three
algorithms performed equally poorly in predicting stroke
events. The Stroke RiskometerTM will be continually developed
and validated to address the need to improve the current
stroke risk scoring systems to more accurately predict stroke,
particularly by identifying robust ethnic/race ethnicity group
and country specific risk factors.
Key words: prevention, stroke prediction, Stroke RiskometerTM App,
validation
Introduction
Despite a steady decrease in stroke mortality over the last two
decades (1), the global burden of stroke is increasing. Almost 17
million people are affected by stroke every year (68% increase
from 1990) and there were 33 million stroke survivors in the
world in 2010 (84% increase from 1990), many with disability (2).
Unlike 30–40 years ago when most strokes occurred in people
aged ≥75 years, now most (>60%) strokes affect people younger
than 75 years (2). This, together with the global epidemic of major
stroke risk factors (3,4), including diabetes (5) and overweight
(6), suggests that the burden of stroke is likely to increase in
the future, unless more effective prevention strategies are
implemented.
As most (>70%) strokes are first-ever strokes, the prevention
of first-ever stroke is a major priority. The two main approaches
to the prevention of first-ever stroke are the population-wide
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‘mass’ approach (reducing the level of exposure to stroke risk
factors in all people in the region regardless of the individual’s
level of risk factors), and the individual-based ‘high risk’
approach. The ‘high-risk’ aims to identify individuals at risk of
stroke (e.g. people with elevated blood pressure, dyslipidaemia,
atrial fibrillation and carotid artery stenosis), and to modify their
risk factors, and risk, accordingly [current methods of assessing
stroke risk include two established stroke risk score prediction
algorithms – the Framingham Stroke Risk Score (FSRS) (7) and
QStroke (8)]. Although those with high-risk stroke benefit most
from prevention strategies, the highest number of strokes and
cardiovascular disease occur in people with only a mildly
increased risk (9–11), mainly because there are greater numbers
of people in this category of risk [according to Dalton et al. (12),
about 90% of UK people aged 40–74 have low 10-year risk of
stroke (<20%) as determined by QRisk2]. However, the general
population, amongst whom most future strokes will arise, do not
readily access and utilize these prediction models; the vast
majority of people do not know their risk of having a stroke, do
not know their risk factors, and do not know what to do about
it (13–15).
Recent advances in mobile (smartphone) technologies and
their worldwide use (about 1·4 billion users) offer unique oppor-
tunities to utilize these technologies for improving health and
reducing burden from these disorders. Importantly, easily acces-
sible and cost-effective risk-estimation systems are well suited to
the developing world and other regions where access to medical
facilities is limited (16), including elderly populations where
smartphones are being increasingly used (17–19).
In recognition of the importance of e-research into noncom-
municable disease (NCD) initiatives, the United Nations (UN)
Economic and Social Council, the International Telecommunica-
tion Union (ITU) and the World Health Organization (WHO)
have recently (June 2013) launched a new mHealth initiative for
improving NCD prevention, treatment and policy enforcement
(20). In order to inform and support these UN/ITU/WHO
efforts, and to increase general awareness about stroke and its risk
factors as well as to improve stroke and NCD prevention on an
individual level, The National Institute for Stroke and Applied
Neurosciences, AUT University recently developed an app called
the Stroke RiskometerTM. This app utilizes recent advances in risk
presentation/communication (21,22), international guidelines on
stroke and CVD prevention (23–28) and has the potential to
significantly improve stroke and NCD prevention (29). The
Stroke RiskometerTM algorithm was derived from the Framing-
ham Stroke Risk Score (FSRS) prediction algorithm (7) and
enhanced to improve accessibility and to include several addi-
tional major risk factors shown to be important for stroke, largely
based on the INTERSTROKE study (4).
Endorsed by the World Stroke Organization, World Federation
of Neurology and International Association on Neurology and
Epidemiology, the app provides estimates of the absolute risk of
stroke within the next 5 and 10 years for individuals aged ≥20
years. Importantly, the Stroke RiskometerTM provides not only
their absolute risk of stroke development but also a baseline risk
for comparison, thus allowing users to compare their risk of
stroke with someone of the same age and gender who has no risk
factors. The former represents a new paradigm for high-risk
stroke prevention strategy (29), and enables a refined presenta-
tion of the traditional threshold-based approach in which people
are categorized into low, moderate, and high-risk groups. This
procedure enables not only those at high levels of risk, but also
those at low- to moderate absolute risk, to reduce their risk of
stroke. The app therefore allows a combination of both high-risk
and population strategies, an approach shown to be the most
effective for cardiovascular disease prevention (11).
The aim of this study was to compare the performance of the
Stroke RiskometerTM prediction algorithm with two other com-
monly used stroke prediction algorithms – Framingham Heart
Study Stroke Risk Score (FSRS) prediction algorithm (7) and
QStroke (8).
Methods
Study design and data sources
Three study populations (80 308 person-years of observation in
total) were used to validate the Stroke RiskometerTM algorithm:
the Auckland Regional Community Stroke (ARCOS IV) 2011–
2012 study (30), the Rotterdam Study (1990 – ongoing) (3,31),
and Russian Cohort studies (1992 – ongoing; Dr M Kravchenko,
unpublished data).
The ARCOS study is a population-based stroke register where
all new stroke events (both hospitalized and nonhospitalized, fatal
and nonfatal) in almost 1·2 million Auckland adult residents were
prospectively ascertained using multiple overlapping sources of
the information, including hospital admissions/referrals, commu-
nity general practices and death certificates etc. (details of the
study methodology have been described elsewhere) (30). For the
purpose of the validation of the Stroke RiskometerTM we used a
sub-set of ARCOS IV data on strokes in people aged 21–95 years
(n = 410).
The Rotterdam Study has been described previously (3). It is an
ongoing prospective population-based cohort study that focuses
on the causes and consequences of chronic and disabling diseases
in the elderly (31). The cohort started enrolment in 1990 and
included 7983 participants aged ≥55 years living in Ommoord, a
district of the city of Rotterdam in the Netherlands (participation
rate 78%). Follow-up was complete until January 1, 2012, for
97·1% of potential person-years (32). The Rotterdam study con-
tributed data from n = 7713 individuals who ranged in age from
55–90 years.
Russian cohort studies were conducted in Moscow (n = 412),
Ulyanovsk (n = 512), Nal’chik (n = 177) and Minsk (n = 277)
over various time periods starting from 1992. Study participants
(men and women; age range 39–66 years) were followed up from
12 years (Moscow) to four-years (Ulyanovsk, Nal’chik and
Minsk). The World Health Organization stroke diagnostic criteria
(33) were used and a diagnosis of stroke was confirmed by a study
neurologist across all these studies (over 90% of stroke patients
had brain neuroimaging to establish a pathological type of
stroke). All these studies have been approved by the local Ethics
Committees.
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Stroke risk factors and algorithm development
Risk scores from three stroke predictors were generated. Each
scoring algorithm utilized a series of known or hypothesized
stroke risk factors (Table 1), some of which are in addition to
those used in the FSRS and are the central targets in the new
WHO Global Action Plan for the NCD 2013–2020 (34). Distri-
bution of each risk factor for each data set is listed in Table 2.
The Stroke RiskometerTM algorithm was derived from the
Framingham Stroke Risk Score (FSRS) prediction algorithm (7)
but enhanced to include several additional major risk factors
shown to be important for both ischaemic and haemorrhagic
strokes, largely based on the INTERSTROKE study (4). The
additional variables are listed in Table 1. Questions were based
on recall such as ‘Have you ever been told by a doctor that you
have atrial fibrillation (irregular heartbeats)?’ and ‘Have you ever
been told by a doctor that you have left ventricular hyperten-
sion?’ such that no immediate medical test (e.g. an ECG is
required) in order for users to provide an answer. These ques-
tions have been used and validated in cross-sectional studies (4).
Beta-coefficients for each additional variable were derived from
current literature and discussed amongst by a panel of stroke
and health experts of the Stroke RiskometerTM Collaboration.
Based on these discussions and available evidence, the following
risk scores were added to the FSRS (7) risk score: 0·20 for being
non-Caucasian (23,35), 0·20 for poor diet (i.e., consuming less
than six servings of fruits and vegetables per day) (4), 0·10 for
high alcohol consumption (i.e., consuming two or more stan-
dard drinks per day) (4,36,37), 0·10 for low physical activity
(i.e., less than 2·5 hours per week) (15,23), 0·05 for family
history of stroke or heart attack (23,38–41), 10 (for 5-year risk)
and 15 (for 10-year risk) for previous stroke or transient ischae-
mic attack (TIA) (42), 1·80 for any cognitive problems and 1·40
for memory problems but no cognitive issues (43), 1·20 for pre-
vious traumatic brain injury (44), 0·20 plus 0·10 for any unit
(0·01) increase in waist-to-hip ratio above 0·96 for males and
0·80 for females (45). In the absence of waist-to-hip ratio
data we used BMI and scored 1·02 plus 0·10 for every unit
(1 kg/m2) above 24 kg/m2 for Chinese, or above 23 kg/m2
for South Asians or above 25 kg/m2 for all other ethnicities (46)
[different cut-off criteria for Chinese people were based on rec-
ommendations from the Chinese National Centre for Cardio-
vascular Disease (W. Wang, personal communication)]. In the
absence of both waist-to-hip ratio and BMI data, waist circum-
ference measures can be used adding 1·02 per unit (1 cm) above
103 cm for males and 89 cm for females (45). As each of the
additional risk factors was added to the algorithm separately
without taking into account interactions between the risk
factors, we applied conservative beta-estimates to reduce the
chance of overestimating the stroke risk (47,48). Algorithm
testing prior to the app launch used a number of different
methods. A very large number of hypothetical cases (many hun-
dreds of different combination of risk factors) were entered into
the tool to identify problems requiring resolution before clinical
use. The tool then underwent clinical evaluation by stroke
experts and general practitioners to compare the estimated
5-year and 10-year risk.
Table 1 Stroke RiskometerTM variables
Variables Definition
Age* In years
Gender* Males or Females
SBP* Systolic blood pressure measured
in mm/Hg
Antihypertensive treatment* Any blood pressure lowering
medications or
antihypertensive medicines
No = 0, Yes = 1
Diabetes* Yes = 1, No = 0
CVD risk* History of CVD (heart attack or
peripheral artery disease)
Yes = 1, No = 0
Smoking status* Never, Ex-Smoker, Current
Atrial fibriliation* Yes = 1, No = 0
Left ventricular hypertrophy by
ecg*
Yes = 1, No = 0
Family history of stroke or heart
attack*
Yes = 1, No = 0
Alcohol consumption More than 2 standard drinks per
day.
Stress Significant stress as determined
by the patient.
Diagnosis of anxiety or
depression.
Low physical activity Less than 2·5 hours per week.
Waist to hip ratio (WHR) In males, if WHR > 0·96 then
add 0·20 + 0·10 for every unit
(0·01) above this threshold
In females, if WHR > 0·80 then
add 0·20 + 0·10 for every unit
(0·01) above this threshold
Non-Caucasian Caucasian = 0,
Non-Caucasian = 1
Poor diet Less than six servings of fruit and
vegetable per day = 1,
More than or equal to six
servings of fruit and
vegetables per day = 0
Cognitive problems or
dementia
Yes = 1, No = 0
Poor memory No cognitive problems but has
poor memory
Yes = 1, No = 0
Previous TBI Previous Traumatic Brain Injury
Yes = 1, No = 0
BMI If WHR not available. We added
0·10 for every unit (1) above
24 kg/m2 for Chinese, or
above 23 kg/m2 for South
Asians or above 25 kg/m2 for
all other ethnicities
Waist circumference If WHR and BMI not available.
We added 1·02 per unit
(1 cm) above 103 cm waist
circumference for males and
89 cm for females
Variables denoted with an asterix (*) comprise the existing Framing-
ham Stroke Risk Score (FSRS) algorithm where the beta-coefficients
differ for males and females. Variables in bold are new additions to the
Stroke RiskometerTM.
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Algorithm validation
The performance of the Stroke RiskometerTM was tested across
three data sets (ARCOS, Russian and Rotterdam) as greater pre-
cision is gained when assessing risk prediction models using mul-
tiple epidemiologic studies compared to single-studies (49). We
also compared performance of the Stroke RiskometerTM with the
FSRS (7) and QStroke (8) risk score equations. The five-year
estimated risk of stroke for Russian and Rotterdam cohorts was
calculated across the three different prediction algorithms. Esti-
mates for 10-year stroke risk score were generated only for the
Rotterdam study where data were available over a span of 10 years.
Follow-up data for the ARCOS were limited to one-year and for
Russian data sets – 4 to 12 years. We calculated Harrels C-statistic
and Somer’s D-statistic to measure discrimination (the ability of
the algorithms to discriminate between stroke and nonstroke
events). C-statistic values of 0·50 represent chance and 1 denotes
the ability of the risk score to discriminate perfectly. D-statistics
over 0·10 indicate that the risk score has a good ability to differ-
entiate between an event and nonevent. Receiver operating char-
acteristics (ROC) curve, Area Under the ROC Curve (AUROC)
with 95% confidence intervals within each data set, sensitivity and
specificity of each algorithm were also analyzed. R2 statistic was
calculated to indicate the level of variability accounted for by each
prediction algorithm. Calibration was assessed using the H-L test
(for goodness-of-fit statistics to examine differences between the
observed and predicted risks from each algorithm) All analyses
were performed in R (version 3·0·2) (50).
Results
Validation cohorts
A total of 752 new strokes that developed in a sample of 9501
individuals over the follow-up period (80 308 person-years of
observation) across three studies (ARCOS, Russia and Rotter-
dam) were utilized to investigate the recently derived stroke risk
prediction tool algorithm Stroke RiskometerTM against two estab-
lished stroke risk score prediction algorithms [FSRS (7) and
QStroke (8)]. The three data sets differed in their distribution of
stroke outcomes and predictor variables required for each algo-
rithm. The ARCOS data set was comprised of stroke only data
whilst the Russian database was generated through a new cohort
study, with 3·2% total strokes being observed. Of the Rotterdam
study, 8·4% was comprised of strokes.
None of the three studies had all variables required for the
Stroke RiskometerTM algorithm. The Russian data set was the
most recent of the three data sets analyzed here so the average age
was lowest (50 years for males and females; Table 2). Individuals
in ARCOS and the Rotterdam study were similar in age (males 69
years and females 72 years). The Russian data set had the lowest
average systolic blood pressure (SBP) while ARCOS had the
highest. Both the Rotterdam and ARCOS studies had similar SBP
values for males and females whilst the Russian data set had
higher values in males. BMI was not recorded in ARCOS but was
similar in males and females of the Russian data set (average for
males = 27·8 kg/m2 and females = 27·5 kg/m2) and comparable
with males and females in the Rotterdam study (average for
males = 25·6 kg/m2 and females = 26·7 kg/m2). As BMI was not
recorded in ARCOS waist circumference was used (for the Stroke
RiskometerTM algorithm); women had greater waist circumfer-
ence (99 cm) than men (97 cm). Due to inclusion of only patients
with stroke, the ARCOS database had the highest percentage of
individuals with diabetes (20%) compared to the Russian data set
(range 4·4–4·8%) and Rotterdam (range 6·1–7·1%). A much
higher proportion of the ARCOS database had individuals with a
history of CVD, previous stroke/TIA event and were of non-
European descent, compared to the Russian and Rotterdam
cohorts (Table 2).
Validation and overall performance of the
Stroke RiskometerTM
As none of the three studies had all variables required for the
Stroke RiskometerTM algorithm, we cannot fully validate this algo-
rithm with the emphasis for the continuing development of the
Stroke RiskometerTM algorithm. We present measures of overall
performance, discrimination and calibration of the Stroke Risko-
meterTM algorithm based on available data. The FSRS and Stroke
RiskometerTM algorithms gave comparable 5-year and 10-year
risk scores for males and females within each data set (Fig. 1). Risk
scores differed substantially by data set, reflecting the availability
of predictors within each cohort. Each algorithm (FSRS, Stroke
RiskometerTM and QStroke) explained 50% of the variation
observed in the ARCOS data set (R2 statistic, Table 3). With fewer
stroke outcomes in the Russian and Rotterdam data sets, the
reported R2 was low across all cohorts for all algorithms, ranging
from 0·31–5·22% (Table 3).
Discrimination
All three algorithms showed poor discriminative ability across
each cohort (C-statistic range 0·50–0·53, D-statistic <0·05,
Table 3). The ROC curves (Fig. 2) show that the FSRS and Stroke
RiskometerTM algorithms behaved similarly for 5-year and
10-year risk scores for males and females, with area under the
ROC curves ranging between 61% and 66% in the Rotterdam
cohort (Fig. 2, Table 3). The QStroke algorithm outperformed the
FSRS and Stroke RiskometerTM algorithms (Table 3).
When all three data sets (ARCOS, Russia and Rotterdam) were
combined the Stroke RiskometerTM and FSRS algorithms had
higher five-year AUROC values for males [FSRS AUROC = 75·0
(95% CI 72·5%–77·6%), Stroke RiskometerTM AUROC = 74·0%
(95% CI 71·3%–76·7%)], for both FSRS and Stroke RiskometerTM
C-statistic = 0·56 and D-statistic = 0·12) and females (FSRS
AUROC = 70·3% (95% 67·9%–72·8%), Stroke RiskometerTM
AUROC = 71·5% (95% CI 69·0%–73·9%), for both FSRS and
Stroke RiskometerTM C-statistic = 0·54 and D-statistic = 0·08).
There was no difference in the AUROC between the FSRS and
Stroke RiskometerTM AUROC (DeLong’s for correlated ROC
curves; males P = 0·013, females P = 0·140). AUROC for QStroke
were considerably lower (males AUROC = 59·7% (95% CI
57·3%–62·0 %), C-statistic = 0·52, D-statistic = 0·04 and for
females AUROC = 71·1% (95% CI 69·0%–73·1%), C-statis-
tic = 0·54, D-statistic = 0·08) (Fig. 2). A statistically significant
difference in the AUROC between the QStroke and Stroke Risko-
meterTM was observed (DeLong’s test for correlated ROC curves;
males P < 0·0001, females P = 0·779).
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Classification, sensitivity and specificity
Mean predicted stroke risk scores were on average higher in the
group of observed stroke outcomes compared to individuals with
no stroke outcome (Supplementary Fig. S1). Sensitivity and
specificity was calculated for FSRS, Stroke RiskometerTM and
QStroke predicted risk scores, which reached accuracy threshold
of 50%, 70%, 80%, 85% and 90% (Table 4). The predicted risk
scores were then categorized into ‘High’ risk (based on reaching
80% accuracy and >80% specificity, Table 4) and ‘Low’ otherwise,
which were compared against each other (Table 5). Sensitivity for
QStroke in males was low (10·6% for accuracy = 80%) compared
to FSRS and Stroke RiskometerTM which had a sensitivity = 53·9%
(FRSR) and 52·3% (Stroke RiskometerTM) for accuracy = 80%.
In the Russian database we observed that both the Stroke
RiskometerTM and FSRS algorithms classified most participants as
high risk (63·6% five-year risk in males and 78·4% five-year risk in
females). As ARCOS had all stroke events we would expect
these to predominately to be categorized as ‘High risk’ this is
observed for FSRS and Stroke RiskometerTM (males = 98·1%
and females = 86·4%). A very high proportion of individuals in
the ARCOS data set were classified as high risk for Stroke
RiskometerTM but low risk on QStroke (males = 97·2% and
females = 48·1% for five-year risk). A high proportion of females
in the Rotterdam study were categorized as low-risk for Stroke
RiskometerTM and high-risk for QStroke (13·2% for five-year risk
in females) compared to 5·5% of males classified as low-risk for
Stroke RiskometerTM and high-risk for QStroke (Table 5).
Calibration
Calibration plots of the predicted risk scores against the observed
event for each tenth of predicted risk, separately for males and
females, are shown in Fig. 3 (all data sources) and Supplementary
Fig. S2 (Russian and Rotterdam cohorts). The Russian cohort
illustrated that the QStroke algorithm was better calibrated for
Fig. 1 Mean predicted risk score by age for Framingham Stroke Risk Score (FSRS) (black), Stroke RiskometerTM (red) and QStroke (green) for five-years for
males and females.
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the data set of all three algorithms, for a database with few strokes
(Supplementary Fig. S2). An improved calibration for the FSRS
and Stroke RiskometerTM algorithms compared to QStroke was
observed for the Rotterdam data set, particularly for females. The
QStroke algorithm was shown to over-estimate stroke risk in
females whilst FSRS and Stroke RiskometerTM over-estimated
stroke risk in males (Supplementary Fig. S2). Visual assessment of
five-year risk scores from the combined data (ARCOS, Russia and
Rotterdam) highlighted that the Stroke RiskometerTM algorithm
was better calibrated compared to QStroke, especially for females
(Fig. 3). All predicted risk scores were not well calibrated to our
data sets (Table 6, H-L tests P < 0·006).
Discussion
The Stroke RiskometerTM is comparable in performance to two
widely used stroke risk scoring systems. The variation found in
our study may be due to several factors. The higher R2 values for
ARCOS are explained by the high number of stroke outcome data
available. Many variables required for the QStroke algorithm were
not available within the ARCOS data set (such as rheumatoid
arthritis, chronic kidney disease, Table 2) therefore it is likely that
the QStroke risk scores we observed under-estimate stroke risk,
particularly amongst males in ARCOS. A large proportion of
females in ARCOS were classified as high risk in both Stroke
RiskometerTM and QStroke scoring (>50%, Table 5). Conversely,
the Rotterdam study had a more complete data set of variables
required for the QStroke algorithm calculation (Table 2), however
this appears to have led to over-estimation of the stroke risk
amongst females (Fig. 1, Supplementary Fig. S2C) and an incon-
sistency across predicted risk scores with 13% categorized as low-
risk for Stroke RiskometerTM and high-risk for QStroke (Table 5).
Sensitivity was low for the QStroke risk scores generated for males
(10·6% for 5-year and 8·9% for 10-year risk scores) and females
(35·9% for 5-year and 36·7% for 10-year risk scores, Table 4),
when specificity was high (= 80%, Table 4) compared to the sen-
sitivity for FSRS and Stroke RiskometerTM for males (53% for
5-year and 10-year risk scores) and females (42% for 5-year and
10-year risk scores, Table 4) for FSRS, and (45% for 5-year and
10-year risk scores, Table 4 for Stroke RiskometerTM, when speci-
ficity was high (= 80%, Table 4). The developers of QStroke have
previously highlighted that their algorithm over-predicts stroke
risk in females (8). It should also be noted that QStroke was
developed for predicting ischaemic stroke specifically, and not for
predicting any type of stroke as developed for Stroke Riskome-
terTM and FSRS.
Fig. 2 Receiver-operating characteristic (ROC) curves for Framingham Stroke Risk Score (FSRS) (black), Stroke RiskometerTM (red) and QStroke (green)
algorithms for 5 and 10-year risks.
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Whilst the discriminative abilities of all three algorithms across
all data sets appeared to be comparable, they were also very low
(C-statistic ranging from 0·51–0·56, D-statistic ranging from
0·01–0·12). H-L calibration statistics illustrated that all of the
predicted risk scores did not align well to observed event data,
P < 0·006. This may be due to the QStroke risk score algorithms
being developed from UK-based data and while the data sets
being utilized here are predominately European, they were not
UK-based individuals. The FSRS has been externally validated in
several different European cohorts but with inconsistent result,
some studies attaining appropriate levels of discrimination but
over-estimation of risk of stroke (51), however other studies have
shown the FSRS has poor discrimination and under-estimates
stroke risk (52). QStroke was recently created and validated in a
subset of the British cohort data used to develop their algorithm
and showed good levels of discrimination; however the authors
did acknowledge a tendency to overestimate female stroke risk
(8). In a large cohort of black and white adults the FSRS overes-
timated observed stroke rates, particularly in certain ethnic sub-
groups where the FSRS suggested there should be approximately
twice as many strokes occurring than was detected (53).
This indicates that there is still a need to improve current stroke
risk scoring systems to more accurately predict stroke risk across
different populations/countries. We have shown that there is a
level of overlap in the variables considered in these algorithms,
however it may be that the weights assigned to each risk factor
need to be generated to be country/or ethnic-specific as some risk
factors may hold more importance in some groups compared to
Table 5 Comparing the scoring of the three risk score algorithms as ‘High’ or ‘Low’ risk for Framingham Stroke Risk Score (FSRS), Stroke RiskometerTM
and the Qstroke algorithm across all validation cohorts (ARCOS, RUSSIA and ROTTERDAM). Thresholds for ‘High’ risk in each algorithm for males and
females was selected for 80% accuracy and >80% specificity (Table 4)
Algorithm Comparison Subset
Number of patients (%)
RUSSIA ARCOS ROTTERDAM
Stroke RiskometerTM vs. FSRS 5-year risk 10-year risk 5-year risk 10-year risk 5-year risk 10-year risk
Low risk on Stroke
RiskometerTM
Low risk on
FSRS
Males 20 (4·16%) 0 (0·00%) 2410 (78·63%) 2522 (82·28%)
High risk on Stroke
RiskometerTM
Low risk on
FSRS
155 (32·22%) 3 (1·40%) 275 (8·97%) 163 (5·32%)
Low risk on Stroke
RiskometerTM
High risk on
FSRS
0 (0·00%) 1 (0·47%) 17 (0·55%) 6 (0·20%)
High risk on Stroke
RiskometerTM
High risk on
FSRS
306 (63·62%) 210 (98·13%) 363 (11·84%) 374 (12·20%)
Low risk on Stroke
RiskometerTM
Low risk on
FSRS
Females 190 (21·18%) 3 (1·40%) 4114 (88·51%) 4188 (90·10%)
High risk on Stroke
RiskometerTM
Low risk on
FSRS
1 (0·11%) 6 (2·80%) 194 (4·17%) 119 (2·56%)
Low risk on Stroke
RiskometerTM
High risk on
FSRS
0 (0·00%) 0 (0·00%) 3 (0·00%) 0 (0·00%)
High risk on Stroke
RiskometerTM
High risk on
FSRS
703 (78·37%) 185 (86·45%) 337 (7·25%) 341 (7·34%)
Stroke RiskometerTM vs. QStroke RUSSIA ARCOS ROTTERDAM
Low risk on Stroke
RiskometerTM
Low risk on
QStroke
Males 20 (4·16%) 0 (0·00%) 2258 (73·67%) 2346 (76·54%)
High risk on Stroke
RiskometerTM
Low risk on
QStroke
439 (91·27%) 208 (97·20%) 376 (12·27%) 279 (9·10%)
Low risk on Stroke
RiskometerTM
High risk on
QStroke
0 (0·00%) 1 (0·47%) 47 (5·51%) 182 (5·94%)
High risk on Stroke
RiskometerTM
High risk on
QStroke
22 (4·57%) 5 (2·34%) 262 (8·55%) 258 (8·42%)
Low risk on Stroke
RiskometerTM
Low risk on
QStroke
Females 190 (21·18%) 3 (1·40%) 3505 (75·41%) 3557 (76·53%)
High risk on Stroke
RiskometerTM
Low risk on
QStroke
686 (76·48%) 103 (48·13%) 168 (3·61%) 116 (2·50%)
Low risk on Stroke
RiskometerTM
High risk on
QStroke
0 (0·00%) 0 (0·00%) 612 (13·17%) 631 (13·58%)
High risk on Stroke
RiskometerTM
High risk on
QStroke
18 (2·01%) 88 (41·12%) 363 (7·81%) 344 (7·40%)
For FSRS: Male 5-year = 13·0%, Male 10-year = 32·0%, Female 5-year = 19·5%, Female 10-year = 42·0%. For Stroke RiskometerTM: Male
5-year = 21·5%, Male 10-year = 43·0%, Female 5-year = 22·0%, Female 10-year = 45·0%. For QStroke: Male 5-year = 8·6%, Male 10-year = 22·0%,
Female 5-year = 23·0%, Female 10-year = 48·0%.
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Fig. 3 Mean predicted risk (%) vs. observed stroke events in deciles of predicted risk for Framingham Stroke Risk Score (FSRS) (black), Stroke RiskometerTM
(red) and QStroke (green) algorithms.
Table 6 Performance of the goodness-of-fit of each algorithm reported as the Hosmer-Lemeshow calibration statistic for Framingham Stroke Risk
Score (FSRS), Stroke RiskometerTM and QStroke against observed stroke events at 5-years for the Russian and 5-years and 10-years for the Rotterdam
and combined (ARCOS, Russia and Rotterdam data set)
Data Risk score Subset
Hosmer-Lemeshow Test
5-year risk 10-year risk
RUSSIA FSRS Females χ2 = 58·12, P ≤ 0·0001
Males χ2 = 133·65, P ≤ 0·0001
Stroke RiskometerTM Females χ2 = 321·92, P ≤ 0·0001
Males χ2 = 36·84, P ≤ 0·0001
QStroke Females χ2 = 3·33, P = 0·912
Males χ2 = 318·81, P ≤ 0·0001
Rotterdam FSRS Females χ2 = 69·95, P ≤ 0·0001 χ2 = 222·02, P ≤ 0·0001
Males χ2 = 100·58, P ≤ 0·0001 χ2 = 356·01, P ≤ 0·0001
Stroke RiskometerTM Females χ2 = 298·95, P ≤ 0·0001 χ2 = 588·20, P ≤ 0·0001
Males χ2 = 2247·03, P ≤ 0·0001 χ2 = 20 297·53, P ≤ 0·0001
QStroke Females χ2 = 21·68, P = 0·006 χ2 = 70·10, P ≤ 0·0001
Males χ2 = 796·93, P ≤ 0·0001 χ2 = 949·04, P ≤ 0·0001
Combined FSRS Females χ2 = 196·70, P ≤ 0·0001 χ2 = 304·91, P ≤ 0·0001
Males χ2 = 153·78, P ≤ 0·0001 χ2 = 726·04, P ≤ 0·0001
Stroke RiskometerTM Females χ2 = 547·29, P ≤ 0·0001 χ2 = 1 811·14, P ≤ 0·0001
Males χ2 = 1699·96, P ≤ 0·0001 χ2 = 11 552·55, P ≤ 0·0001
QStroke Females χ2 = 1441·52, P ≤ 0·0001 χ2 = 270·42, P ≤ 0·0001
Males χ2 = 1587·38, P ≤ 0·0001 χ2 = 1 822·10, P ≤ 0·0001
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others (54). It is also likely that there are further unknown stroke
risk factors that still need to be identified and included in a stroke
prediction assessment tool. For one such example we refer to the
recent evidence from Yusuf et al. (55) that populations from low
to middle-income countries are at highest risk of cardiovascular
events have the lowest risk factor burden (55), suggesting that the
major ‘missing piece in the equation’ of the effective CVD pre-
vention is the impaired ability of resource-limited health systems
to effectively identify and modify cardiovascular risk. It is our
expectation that the Stroke RiskometerTM will be further devel-
oped to account for these factors (we are currently collecting data
on country) such that in future iterations of the Stroke Riskome-
terTM we hope to refine the algorithm to be able to provide
country and ethnic specific-stroke risk prediction estimates, using
both current research such as Yusuf et al. (55) and data collected
from the current Stroke RiskometerTM App to improve overall
predictability and applicability of our algorithm across all popu-
lations. Furthermore, an algorithm for all major noncommuni-
cable disease, such as stroke, ischaemic heart disease (IHD),
dementia and diabetes mellitus that share common risk factors,
should be developed and validated in different populations. The
main weakness of this validation study was that analyses were
restricted due to the lack of currently available data on the vari-
ables shown to be important determinants of stroke.
The Stroke RiskometerTM availability on a portable device
(smartphone) with constant proximity to the user, enables
individuals to assess their own risk of stroke in the privacy
and comfort anytime, anywhere. Unlike web-based versions, no
internet connection required to use the app or access its infor-
mation. In addition, the app offers a higher level of interactivity
via sending direct reminders to the smartphone that is always on
hand when needed. Moreover, the availability of the app on the
smartphone app stores that has global reach, and vast consumer
base of various age groups allows wide range of consumers to
benefit from the stroke risk assessment tool and allows the
crowdsourcing of large research database. Finally, users who are
at increased (even slightly increased) risk are provided with ways
to reduce their risk of stroke according to their individual risk
profile and recommended to seek medical attention. This could
rapidly transform epidemiologic research and monitoring of
health status of individuals, especially in the area of chronic
NCD (17).
Current risk scores will inevitably become outdated with
improvements in clinical outcomes and data recording and
changes in population demographics (56). With the Lite version
of the Stroke RiskometerTM being made freely available globally
on both iOS and Android smartphones and users invited to
partake in a large-scale study we will have the potential to amass
a large database. Ethical approval for the study has been received.
Anonymous data from individuals who consent to participate in
the study will be collected and securely stored at study coordinat-
ing centre (AUT University, NZ). The aim of these planned epi-
demiological studies based on the Stroke RiskometerTM will be to
generate a global, population-specific stroke and NCD risk
scoring system. We will further assess the Stroke RiskometerTM in
a cohort study to establish the efficiency of the algorithm and
assess if the new collections of recommendations are useful for
motivating users to actively reduce their risk of stroke.
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deciles of predicted risk for Framingham Stroke Risk Score
(FSRS) (black), Stroke RiskometerTM (red) and QStroke (green)
algorithms for males (left) and females (right) for (A) 5-year
predicted risks for the Russian data set, (B) 5-year predicted risks
for the Rotterdam data set and (C) 10-year predicted risks for the
Rotterdam data set.
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